Sage Group’s Strong Financial Performance and Positive Outlook Earns Buy Rating
Analyst Charles Brennan from Jefferies maintained a Buy rating on Sage Group plc (SGE – Research Report) and keeping the price target at ...
The Australian5d
EBR reports milestone quarter, final FDA review for WiSE CRT system
Medtech EBR has reported a milestone quarter, highlighted by the final submission of its PMA application for the WiSE CRT system to the FDA. The company submitted its final module of PMA ...
Stockhead on MSN5d
EBR reports milestone quarter, final FDA review for WiSE CRT system
Medtech EBR has reported a milestone quarter, highlighted by the final submission of its PMA application for the WiSE CRT ...
Business Insider2d
Citi Reaffirms Their Buy Rating on Sage Group plc (SGE)
Citi analyst Balajee Tirupati maintained a Buy rating on Sage Group plc (SGE – Research Report) today and set a price target of £13.50. The company’s shares closed last Friday at p1,067.00. Don't Miss ...
ENDPOINTS NEWS2d
A rare neu­ro­log­i­cal dis­ease is Sage’s last, best hope af­ter fail­ures in de­pres­sion
In 2010, neuroscientist and former Eli Lilly research leader Steve Paul started a company that he hoped would spark a revolution in drug discovery built around a class of compounds dubbed ...